Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07598370 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of LY3439539 in Participants With Alzheimer's Disease

StatusRecruiting
PhasePhase 1
Started2026-05-21
View on ClinicalTrials.gov ↗
The purpose of this study is to see how LY3439539 affects certain proteins found in the spinal fluid of participants with Alzheimer's disease. Participation in the study will last approximately 9 months with visits about once a month.

Amendment history 4 changes detected by DataLookout

2026-09-05
Trial sites expanded: 8 → 11 locations
2026-07-21
Primary completion pushed: 2027-05 → 2027-08
2026-07-21
Completion pushed: 2027-05 → 2027-08
2026-06-17
Recruitment opened
Trial Details
NCT Number NCT07598370
Lead Sponsor Eli Lilly and Company
Conditions Alzheimer Disease
Enrollment 30 participants
Start Date 2026-05-21
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-09-04